A Single-Arm, Phase II Study Of Amivantamab (Ami), Lazertinib (L) And Pemetrexed (P) For First-Line Treatment Of Recurrent/Metastatic Non-Small Cell Lung Cancers (Nsclcs) With Epidermal Growth Factor Receptor Mutations In Exons 19 Or 21 (Egfr 19/21): Amigo 1 (Lacog0821)
Amivantamab;Lazertinib;Pemetrexed
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Single-Arm, Phase II Study Of Amivantamab (Ami), Lazertinib (L) And Pemetrexed (P) For First-Line Treatment Of Recurrent/Metastatic Non-Small Cell Lung Cancers (Nsclcs) With Epidermal Growth Factor Receptor Mutations In Exons 19 Or 21 (Egfr 19/21): Amigo 1 (Lacog0821) ### Output: Amivantamab;Lazertinib;Pemetrexed